Dr. Shum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7595 Anagram Dr
Eden Prairie, MN 55344Phone+1 612-573-2220Fax+1 612-573-2274
Education & Training
- Baylor College of MedicineClass of 2014
Certifications & Licensure
- SD State Medical License Active through 2027
- MA State Medical License 2020 - 2026
- MN State Medical License 2024 - 2025
- ND State Medical License 2024 - 2025
- TX State Medical License 2024 - 2025
- WI State Medical License 2024 - 2025
Publications & Presentations
PubMed
- 8 citationsPhase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.Frank Y Lin, Austin Stuckert, Candise Tat, Mark White, Lucia Ruggieri
Journal of Clinical Oncology. 2024-08-10 - 4 citationsConstitutive Interleukin-7 Cytokine Signaling Enhances the Persistence of Epstein-Barr Virus-Specific T-Cells.Sandhya Sharma, Tim Sauer, Bilal A Omer, Thomas Shum, Lisa A Rollins
International Journal of Molecular Sciences. 2023-10-31 - 11 citationsA Costimulatory CAR Improves TCR-based Cancer Immunotherapy.Bilal Omer, Mara G Cardenas, Thomas Pfeiffer, Rachel Daum, Mai Huynh
Cancer Immunology Research. 2022-04-01
Journal Articles
- Retraction Note: A Homing System Targets Therapeutic T Cells to Brain CancerNabil Ahmed, Fong W Lam, Meenakshi Hegde, Jordan S Orange, Thomas Shum, Rakesh K Jain, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: